Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CRx-102 versus components in active rheumatoid arthritis
2007-003069-42Phase 2Terminated
- Sponsor
- CombinatoRx
- Start
- Aug 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of prednisolone + dipyridamole in rheumatoid arthritis (RA) (4 arms), sponsored by CombinatoRx. Primary endpoint: ACR20 response. Started Aug 2007; status: terminated.
02
Drugs
prednisolone + dipyridamole
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2007-003069-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003069-42.